Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13)
Authors:
- Y HayashiYHY Hayashi
- Y HonmaYHY Honma
- 18 January 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (3) , 375-384
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 54 references indexed in Scilit:
- Dicarba-closo-dodecaboranes as a Pharmacophore. Retinoidal Antagonists and Potential Agonists.Chemical and Pharmaceutical Bulletin, 1999
- Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)Leukemia, 1997
- Sinful repressionNature, 1997
- The Transcriptional Coactivators p300 and CBP Are Histone AcetyltransferasesCell, 1996
- Enhancement of HL-60 Differentiation by a New Class of Retinoids with Selective Activity on Retinoid X ReceptorJournal of Biological Chemistry, 1995
- Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL‐60 leukemic cell lineInternational Journal of Cancer, 1994
- A human retinoic acid receptor which belongs to the family of nuclear receptorsNature, 1987
- Clinical pharmacology of sodium butyrate in patients with acute leukemiaEuropean Journal of Cancer and Clinical Oncology, 1987
- Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60European Journal of Cancer and Clinical Oncology, 1983
- Butyric acid: A small fatty acid with diverse biological functionsLife Sciences, 1980